Skip to main content
. 2017 Dec 8;24(1):6–12. doi: 10.5761/atcs.oa.17-00108

Table 2. Survival analyze.

  N = 3 years 5 years 10 years Univariate analysis P value

Sex         0.93
 Male 22 87% 87% 58%  
 Female 17 100% 100% 45%  
Histological subtype         0.11
 B1 8 100% 100% 75%  
 B2 16 94% 94% 94%  
 B3 6 100% 100% 100%  
 C 9 75% 75% -  
MG presence         0.98
 Yes 18 100% 100% 37%  
 No 21 86% 86% 71%  
Osserman         0.74
 1 21 86% 86% 71%  
 2 6 100% 100% 0%  
 3 9 100% 100% -  
 4 3 100% 100% 50%  
Neoadjuvant         0.80
 Yes 25 88% 88% 51%  
 No 14 100% 100% 67%  
Number of the operation         0.81
 Primary 26 90% 90% 72%  
 Secondary 9 100% 100% -  
 Tertiary 4 100% 100% 50%  
Operation type         0.77
 PP 3 67% 67% 67%  
 P/D 19 100% 100% 50%  
 LE 17 92% 92% 38%  
Preferred incision         0.27
 Sternotomy 18 93% 93% 70%  
 Thoracotomy 13 92% 92% -  
 Sternotomy + thoracoscopy 4 100% 100% -  
 Sternotomy + thoracotomy 4 100% 50% -  
Complications         0.78
 Yes 12 92% 92% 46%  
 No 27 94% 94% 62%  
Adjuvant         0.08
 None 4 75% 75% -  
 CT 13 100% 100% 40%  
 RT 8 83% 83% 83%  
 CT-RT 14 100% 100% 100%  

PP: pleuropneumonectomy; P/D: radical pleurectomy/decortication; LE: local excision of the pleural/pericardial/diaphragmatic implants; CT: chemotherapy; RT: radiotherapy; CT + RT: chemo-radiotherapy